Osprey Medical Inc (OSP:ASX)


right-arrow Created with Sketch. 0.02 (2.22%)
MCAP $23.60M
Last trade 16.10pm 22/10/2021 20mins delayed

Latest Announcements

20/10/2021 Price SensitivePSOSPOsprey Medical Inc
14/10/2021OSPOsprey Medical Inc
13/10/2021OSPOsprey Medical Inc
11/10/2021OSPOsprey Medical Inc
30/09/2021OSPOsprey Medical Inc
30/09/2021OSPOsprey Medical Inc
30/09/2021OSPOsprey Medical Inc
23/09/2021OSPOsprey Medical Inc

Company Overview

Osprey Medical Inc. is a medical device company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company's products include AVERT Plus System and DyeVert System. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.

OSP in the news

Osprey Medical (OSP) receives medical device licence (MDL) approval to expand its…
Despite the ongoing COVID-19 pandemic, Osprey Medical (OSP) has continued to rebound…
Medical device maker Osprey Medical (OSP) has been awarded a Supplier Horizon…
Medical device manufacturer Osprey Medical (OSP) has struck a deal to have…

Search Previous Announcements